Predictors for recurrent ischemic stroke in patients with watershed infarct induced by intracranial artery stenosis.
Zhenzhen Li, Xinwei Liu, Huiling Sun...
https://pubmed.ncbi.nlm.nih.gov/40288288/Actively Recruiting
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2026-04-15
500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the roles of different types of non-coding RNA, including circular RNA circRNA, micro-RNA miRNA, and long non-coding RNA lncRNA, in people who have had an acute ischemic stroke compared to healthy individuals. The study aims to find specific RNA patterns that could help detect and predict outcomes in acute ischemic stroke. This observational research involves analyzing the expression of these RNAs using advanced sequencing techniques to better understand their clinical significance. The study includes two groups patients diagnosed with acute ischemic stroke and healthy control participants. Researchers will perform next-generation sequencing to examine the RNA profiles of these participants. The study will identify distinctive RNA expression patterns and verify candidate RNA molecules as potential biomarkers for diagnosis and prognosis. A diagnostic or predictive model will be developed using statistical methods based on the RNA data. Participants will undergo blood sampling to collect RNA for sequencing and analysis. Researchers will assess RNA expression changes and their correlation with inflammatory factors, stroke-related infections, and outcomes over a 90-day follow-up period. The primary outcome focuses on differences in RNA expression patterns at 90 days. Secondary outcomes include the prognostic value of RNA markers, associations with inflammation and infections, and dynamic RNA changes during follow-up. Participants will be monitored for up to 90 days to gather these data.
CONDITIONS
Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
J
Junshan Zhou, M.D.
Q
Qiwen Deng, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nanjing First Hospital, Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 72 hours of symptom onset
Participants undergo blood sampling and genetic sequencing to analyze expression patterns of circulating non-coding RNAs related to acute ischemic stroke.
1 visit (in-person)
Duration - Up to 90 days
Participants are followed up to observe dynamic changes of circulating non-coding RNAs and their correlation with stroke prognosis and related factors.
Multiple visits during follow-up period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Zhenzhen Li, Xinwei Liu, Huiling Sun...
https://pubmed.ncbi.nlm.nih.gov/40288288/Qi-Wen Deng, Shi Huang, Shuo Li...
https://pubmed.ncbi.nlm.nih.gov/34511974/S Li, G Lu, D Wang...
https://pubmed.ncbi.nlm.nih.gov/32337817/Huiling Sun, Shuo Li, Zhaohan Xu...
https://pubmed.ncbi.nlm.nih.gov/34980176/Wenxia Chen, Hanqing Zhang, Zhenzhen Li...
https://pubmed.ncbi.nlm.nih.gov/38902691/Qi-Wen Deng, Shuo Li, Huan Wang...
https://pubmed.ncbi.nlm.nih.gov/29997237/Nanjing First Hospital, Nanjing Medical University
Lead Sponsor